2003
Danillo Perrotti, MD, PhD
James Cancer Hospital and Richard J. Solove
Research Institute, Ohio State University, Columbus,OH
Research initiated at Thomas Jefferson University, Philadelphia, PA
Role of BCR/ABL Oncogene in Suppression
of Neutrophilic Differentiation
Grant made possible by The Johnny Mercer Foundation
In Memory of Johnny Mercer

William Tse, MD
Case Western Reserve University School of Medicine, Cleveland, OH
Research Initiated at Fred Hutchinson
Cancer Research Center Clinical Significance of AF1q Gene in Myeloid and Lymphoid Leukemia
Grant made possible by Ford Motor Company

Loren D. Walensky, MD, PhD
Dana Farber Cancer Institute, Boston, MA
Targeting Apoptosis in Leukemia by Chemical Design
Grant made possible by Cell Therapeutics

Artur Slupianek, PhD
College of Science and Technology Center for Biotechnology, Temple University, Philadelphia, PA
Role of Rad51 Family Members in Drug Resistance Induced by BCR/ABL
Grant made possible by The Muriel Fusfeld Foundation
In Memory of Muriel Fusfeld

Emilia Albesiano, PhD
North Shore - Long Island Jewish
Research Institute, Manhasset, NY
Identification of Activation-Induction Cytidine
Deaminase Expression in B Cell Type Chronic
Lymphocytic Leukemia Cells
Grant made possible by The Ambassador Felix Schnyder Fund
In Memory of Ambassador Felix Schnyder

Susan Kambhampti, MD
Northwestern School of Medicine
Northwestern University, Chicago, IL
Role of Protein Kinase C-Delta in the Induction of All-Trans-Retinoic Acid Responses in APL Cells
Courtesy of the Madoff Family

Michael Hemann, PhD
Cold Spring Harbor Laboratory,
Cold Spring Harbor, NY
Improving the Characterization and Treatment of Leukemia and Lymphoma
Grant made possible by The Ambassador Felix Schnyder Fund
In Memory of Ambassador Felix Schnyder

Nicholas Chiorazzi, MD in association with
Charles C. Chu, PhD
North Shore-Long Island Jewish
Research Institute, Manhasset, NY
Cellular and Molecular Characterization of the
Pathogenic Autoantibody-producing B Lymphocytes from Patients with Systematic Lupus Erythematosus
Grant made possible by The Muriel Fusfeld Foundation
In Memory of Muriel Fusfeld

2002
Benjamin Boettner, PhD
Cold Spring Harbor Laboratory,
Cold Spring Harbor,NY
Identification and Characterization of Genes
Regulated by BCR-ABL, The Causative Agent of
Chronic Myelogenous Leukemia
Grant made possible by The Ambassador Felix Schnyder Fund
In Memory of Ambassador Felix Schnyder

Kevin D. Bunting, PhD
American Red Cross Holland Laboratory, Rockville,MD
Functional Characterization of the Role of the Novel Mixed Lineage Leukemia-Associated AFIq Gene Product in Myeloid Leukemia Cell Differentiation
Grant Made Possible by The Johnny Mercer Foundstion
In Memory of Johnny Mercer
Nicholas Chiorazzi, MD in association with

Charles C. Chu, PhD
Laboratory of Molecular Immunology/Gene
Activation, North Shore-Long Island Jewish
Research Institute, Manhasset, NY
Cellular and Molecular Characterization of the
Pathogenic Autoantibody-producing B
Lymphocytes from Patients with Systematic Lupus
Erythematosus
Grant made possible by The Muriel Fusfeld Foundation
In Memory of Muriel Fusfeld

Yih-Pai Chu, PhD
North Shore-Long Island Jewish
Research Institute, Manhasset, NY
The Role of Tumor Necrosis Factor-alpha in the
Proliferation and Survival of the Leukemic Cells in B Cell Type Chronic Lymphocytic Leukemia
Grant made possible by The Ambassador Felix Schnyder Fund
In Memory of Ambassador Felix Schnyder

Dilip Patel, MD
Long Island Jewish Medical Center,
New Hyde Park, NY
Initiation of Study of Familial Chronic
Lymphocytic Leukemia (CLL) Starting with a
Systematic Survey of CLL Patients Who Have a
First-Degree Relative with CLL or a Related
Lymphoid Disorder
In Honor of Kanti R. Rai, MD

Constantine Mitsiades, MD
Dana Farber Cancer Institute, Boston, MA
Biologically Based Therapeutic Strategies to
Enhance the Activity of TRIAL/Apo21 Against
Leukemias, Lymphomas and Myeloma
Grant made possible by Ford Motor Company

Joseph Schwartz, MD
Memorial Sloan-Kettering Cancer Center,
NY, NY
Leukemia Immunotherapeutic Approaches Using the WT-1 Antigen as a Target
In Memory of Michael J. Lopez

Richard D. Huhn, MD
Coriell Institute for Medical Research, Camden, NJ
Studies of the Cellular Basis of Delayed Platelet
Engraftment Following Transplantation of Culture Expanded Cord Blood Stem/Progenitor Cells
In Memory of Michael Lopez
Grant Made Possible by The Muriel Fusfeld Fundation

Jeffrey M. Lipton, MD, PhD
Schneider Children’s Hospital,
New Hyde Park, NY
Financial Support for an Additional Childlife Specialist